Table 1.
Target | Peptide sequence | Modification | m/z |
---|---|---|---|
Trp 84 | 72VDEQFPGFSGSEMWNPNREMSEDCLY96 | +16 Da +32 Da +48 Da +64 Da |
1047.33+ 1052.63+ 1058.13+ 1063.43+ |
Trp 233 | 222AILQSGSPNCPWASVSVAEGR242 | +32 Da | 1109.62+ |
Trp 279 | 270KPQELIDVEWNVLPFDSIFR289 | +32 Da | 826.43+ |
268EKKPQELIDVEWNVLPFDSIFR289 | +32 Da | 912.03+ | |
Trp 432/435 | 431VWPEWMGVIHGY442 | +16 Da | 745.42+ |
422FFNHRASNLVWPEWMGVIHGY442 | +48 Da | 870.13+ | |
424NHRASNLVWPEWMGVIHGY442 | +16 Da | 761.43+ |
Modifications detected in MS correspond to the oxidation of several residues as follow: +16 Da = Met sulfoxide; +32 Da = NFK or two Met sulfoxides; +48 Da= Met sulfoxide plus NFK; +64 Da = two Met sulfoxides plus NFK.
CAM indicates derivatization to carbamidomethyl derivatives of cysteine residues detected with an additional 57 Da.
TcAChE was identified using the Swiss Protein Data Bank (accession code P04058).